348 related articles for article (PubMed ID: 31504235)
1. YTH domain family 2 promotes lung cancer cell growth by facilitating 6-phosphogluconate dehydrogenase mRNA translation.
Sheng H; Li Z; Su S; Sun W; Zhang X; Li L; Li J; Liu S; Lu B; Zhang S; Shan C
Carcinogenesis; 2020 Jul; 41(5):541-550. PubMed ID: 31504235
[TBL] [Abstract][Full Text] [Related]
2. 6-Phosphogluconate dehydrogenase fuels multiple aspects of cancer cells: From cancer initiation to metastasis and chemoresistance.
Sarfraz I; Rasul A; Hussain G; Shah MA; Zahoor AF; Asrar M; Selamoglu Z; Ji XY; Adem Ş; Sarker SD
Biofactors; 2020 Jul; 46(4):550-562. PubMed ID: 32039535
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting 6-phosphogluconate dehydrogenase enhances chemotherapy efficacy in cervical cancer via AMPK-independent inhibition of RhoA and Rac1.
Guo H; Xiang Z; Zhang Y; Sun D
Clin Transl Oncol; 2019 Apr; 21(4):404-411. PubMed ID: 30182212
[TBL] [Abstract][Full Text] [Related]
4. 6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met.
Chan B; VanderLaan PA; Sukhatme VP
Biochem Biophys Res Commun; 2013 Sep; 439(2):247-51. PubMed ID: 23973484
[TBL] [Abstract][Full Text] [Related]
5. Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence.
Sukhatme VP; Chan B
FEBS Lett; 2012 Jul; 586(16):2389-95. PubMed ID: 22677172
[TBL] [Abstract][Full Text] [Related]
6. Critical Role of 6-Phosphogluconate Dehydrogenase in TAp73-Mediated Cancer Cell Proliferation.
Qiao R; Wei M; Chen H; Zhang X; Zhang J; Gao L; Ma H; Wang Y; Li L
Mol Cancer Res; 2023 Aug; 21(8):825-835. PubMed ID: 37071129
[TBL] [Abstract][Full Text] [Related]
7. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
Liu R; Li W; Tao B; Wang X; Yang Z; Zhang Y; Wang C; Liu R; Gao H; Liang J; Yang W
Nat Commun; 2019 Mar; 10(1):991. PubMed ID: 30824700
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
10. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation.
Zhao X; Lv S; Li N; Zou Q; Sun L; Song T
J Biol Chem; 2024 Apr; 300(4):107152. PubMed ID: 38462165
[TBL] [Abstract][Full Text] [Related]
12. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
[TBL] [Abstract][Full Text] [Related]
13. Gambogic acid exhibits promising anticancer activity by inhibiting the pentose phosphate pathway in lung cancer mouse model.
Zhang Q; Zhang Y; Wang C; Tang H; Ma A; Gao P; Shi Q; Wang G; Shen S; Zhang J; Xia F; Zhu Y; Wang J
Phytomedicine; 2024 Jul; 129():155657. PubMed ID: 38692076
[TBL] [Abstract][Full Text] [Related]
14. Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth.
Shan C; Elf S; Ji Q; Kang HB; Zhou L; Hitosugi T; Jin L; Lin R; Zhang L; Seo JH; Xie J; Tucker M; Gu TL; Sudderth J; Jiang L; DeBerardinis RJ; Wu S; Li Y; Mao H; Chen PR; Wang D; Chen GZ; Lonial S; Arellano ML; Khoury HJ; Khuri FR; Lee BH; Brat DJ; Ye K; Boggon TJ; He C; Kang S; Fan J; Chen J
Mol Cell; 2014 Aug; 55(4):552-65. PubMed ID: 25042803
[TBL] [Abstract][Full Text] [Related]
15. YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma.
Zhong L; Liao D; Zhang M; Zeng C; Li X; Zhang R; Ma H; Kang T
Cancer Lett; 2019 Feb; 442():252-261. PubMed ID: 30423408
[TBL] [Abstract][Full Text] [Related]
16. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation.
Liu T; Wei Q; Jin J; Luo Q; Liu Y; Yang Y; Cheng C; Li L; Pi J; Si Y; Xiao H; Li L; Rao S; Wang F; Yu J; Yu J; Zou D; Yi P
Nucleic Acids Res; 2020 Apr; 48(7):3816-3831. PubMed ID: 31996915
[TBL] [Abstract][Full Text] [Related]
17. 6-Phosphogluconate dehydrogenase (6PGD), a key checkpoint in reprogramming of regulatory T cells metabolism and function.
Daneshmandi S; Cassel T; Higashi RM; Fan TW; Seth P
Elife; 2021 Oct; 10():. PubMed ID: 34709178
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 promotes gallbladder cancer progression and gemcitabine resistance via m6A-dependent DAPK3 degradation.
Bai X; Chen J; Zhang W; Zhou S; Dong L; Huang J; He X
Cancer Sci; 2023 Nov; 114(11):4299-4313. PubMed ID: 37700438
[TBL] [Abstract][Full Text] [Related]
19. N6-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer.
Zhang H; Zhou J; Li J; Wang Z; Chen Z; Lv Z; Ge L; Xie G; Deng G; Rui Y; Huang H; Chen L; Wang H
Cancer Res; 2023 Jul; 83(13):2208-2225. PubMed ID: 37103476
[TBL] [Abstract][Full Text] [Related]
20. SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs.
Hou G; Zhao X; Li L; Yang Q; Liu X; Huang C; Lu R; Chen R; Wang Y; Jiang B; Yu J
Nucleic Acids Res; 2021 Mar; 49(5):2859-2877. PubMed ID: 33577677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
